← Case studies CS—003 · Medical devices · United States

Supporting the seed round for a cleaner way to sterilise.

Company: Chemical-free sterilisation technology, ahead of regulatory clearance
Engagement: 2026
Our role: Advisory board recruitment, investor outreach and investor updates

Half of America’s sterile medical devices are cleaned with a cancer-causing gas. Our client is building a cleaner alternative. We are supporting its seed round.

01 · The problem

Sterilisation still runs on a carcinogen.

Sterile US devices treated with ethylene oxideAbout halfThe single most common sterilisation method

~50%of sterile devices

Hospital patients with an infection caught in care1 in 31On any given day in US hospitals

Emissions cut required of commercial sterilisers90%+Under the EPA’s 2024 rule

Before

Required

Sources: FDA (share of devices sterilised with ethylene oxide), CDC (healthcare-associated infections), EPA final rule of March 2024.

A surgeon working under bright theatre lights

02 · The device

No gas. No chemicals.

A compact system designed to sterilise without toxic gas, chemicals or long aeration, including in places today’s methods struggle to reach. Early independent testing has been strong, and the company is working towards clearance.

03 · The round